Article Versions Notes

Ishigami H, Tsuji Y, Shinohara H, Kodera Y, Kanda M, Yabusaki H, Ito S, Imano M, Yamashita H, Hidemura A, et al. Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial. Journal of Clinical Medicine. 2021; 10(23):5666. https://doi.org/10.3390/jcm10235666

Ishigami, Hironori, Yasushi Tsuji, Hisashi Shinohara, Yasuhiro Kodera, Mitsuro Kanda, Hiroshi Yabusaki, Seiji Ito, Motohiro Imano, Hiroharu Yamashita, Akio Hidemura, and et al. 2021. "Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial" Journal of Clinical Medicine 10, no. 23: 5666. https://doi.org/10.3390/jcm10235666

Ishigami, H., Tsuji, Y., Shinohara, H., Kodera, Y., Kanda, M., Yabusaki, H., Ito, S., Imano, M., Yamashita, H., Hidemura, A., Yamaguchi, H., Fukagawa, T., Oba, K., Kitayama, J., & Seto, Y. (2021). Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial. Journal of Clinical Medicine, 10(23), 5666. https://doi.org/10.3390/jcm10235666